Vytrus Biotech S.A. (VYT) — Cash Flow Quality Index
Latest as of December 2022:
0.50x
Vytrus Biotech S.A. (VYT) has a Cash Flow Quality Index of 0.50x as of December 2022. Operating cash flow of €225.55K is below net income of €452.79K, suggesting accrual-heavy earnings not yet converted to cash. Explore VYT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.50x
Operating CF / Net Income
Operating Cash Flow
€225.55K
EUR
Net Income
€452.79K
EUR
Data as of
Dec 2022
Most recent filing
Vytrus Biotech S.A. Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Vytrus Biotech S.A. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see VYT cash generation efficiency.
Annual Cash Flow Quality Index for Vytrus Biotech S.A. (2020–2025)
Year-by-year earnings quality comparison for Vytrus Biotech S.A..
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▲ +233.2% |
| 2022 | 0.50x | €225.55K | €452.79K | ▼ -65.6% |
| 2021 | 1.45x | €447.92K | €309.17K | ▲ +200.2% |
| 2020 | -1.45x | €-132.47K | €91.60K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.